Nephrogenic Systemic Fibrosis: Clinical Picture and Treatment

Radiologic Clinics of North America

Volumn 47, Issue 5, 2009, Pages 833-840

  Marckmann, Peter ^a   Skov, Lone ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chronic kidney disease; Clinical picture; Diagnosis; Gadolinium; Nephrogenic systemic fibrosis; Renal failure; Treatment

Indexed keywords

ANALGESIC AGENT; CONTRAST MEDIUM; GADOLINIUM; SODIUM THIOSULFATE; STEROID;

ACUTE KIDNEY FAILURE; ANAMNESIS; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONTRACTURE; DIFFERENTIAL DIAGNOSIS; DRUG EXPOSURE; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LUNG DISEASE; NEPHROGENIC SYSTEMIC FIBROSIS; NEUROLOGIC DISEASE; PAIN; PHYSIOTHERAPY; PRIORITY JOURNAL; PRURITUS; REMISSION; REVIEW; SCLEROMYXEDEMA; SKIN BIOPSY; SKIN DISCOLORATION; SKIN MANIFESTATION; SWELLING; SYSTEMIC SCLEROSIS;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; HUMANS; KIDNEY FUNCTION TESTS; NEPHROGENIC FIBROSING DERMOPATHY; RISK FACTORS;

EID: 69649095947     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2009.05.004     Document Type: Review

References (30)

1. Cowper S.E., Robin H.S., Steinberg S.M., et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356 (2000) 1000-1001
2. Daram S.R., Cortese C.M., Bastani B., et al. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 46 (2005) 754-759
3. Marckmann P. Nephrogenic systemic fibrosis: epidemiology update. Curr Opin Nephrol Hypertens 17 (2008) 315-319
4. Broome D.R. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 66 (2008) 230-234
5. Todd D.J., and Kay J. Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity. Curr Rheumatol Rep 10 (2008) 195-204
6. Agarwal R., Brunelli S.M., Williams K., et al. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant 24 (2009) 856-863
7. Varani J., DaSilva M., Warner R.L., et al. Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Invest Radiol 44 (2009) 74-81
8. Grant D., Johnsen H., Juelsrud A., et al. Effects of gadolinium contrast agents in naive and nephrectomized rats: relevance to nephrogenic systemic fibrosis. Acta Radiol 50 (2009) 156-169
9. Pietsch H., Lengsfeld P., Steger-Hartmann T., et al. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents. Invest Radiol 44 (2009) 226-233
10. Marckmann P., Skov L., Rossen K., et al. Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol 69 (2008) 161-168
11. Bangsgaard N., Marckmann P., Rossen K., et al. Nephrogenic systemic fibrosis: late skin manifestations. Arch Dermatol 145 (2009) 183-187
12. Cowper S.E., Rabach M., Girardi M., et al. Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol 66 (2008) 191-199
13. Khurram M., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients. Scand J Urol Nephrol 41 (2007) 565-566
14. Cowper S.E., Su L.D., Bhawan J., et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23 (2001) 383-393
15. Marckmann P. An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital. Eur J Radiol 66 (2008) 187-190
16. Mendoza F.A., Artlett C.M., Sandorfi N., et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35 (2006) 238-249
17. Marckmann P., Skov L., Rossen K., et al. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 22 (2007) 3174-3178
18. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
19. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 (2006) 2359-2362
20. Broome D.R., Girguis M.S., Baron P.W., et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 188 (2007) 586-592
21. Wiginton C.D., Kelly B., Oto A., et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. Am J Roentgenol 190 (2008) 1060-1068
22. Khurana A., Runge V.M., Narayanan M., et al. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (Omniscan). Invest Radiol 42 (2007) 139-145
23. Penfield J.G., and Reilly Jr. R.F. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 3 (2007) 654-668
24. Swaminathan S., and Shah S.V. New insights into nephrogenic systemic fibrosis. J Am Soc Nephrol 18 (2007) 2636-2643
25. Steen H., Giannitsis E., Sommerer C., et al. Acute phase reaction to gadolinium-DTPA in dialysis patients. Nephrol Dial Transplant 24 (2009) 1274-1277
26. Rydahl C., Thomsen H.S., and Marckmann P. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol 43 (2008) 141-144
27. Thomsen H.S., and Marckmann P. Extracellular Gd-CA: differences in prevalence of NSF. Eur J Radiol 66 (2008) 180-183
28. Janus N., Launay-Vacher V., Karie S., et al. Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study. Eur J Radiol (2009) Doi:10.1016/j.ejrad.2008.11.021 [Epub ahead of print]
29. Prince M.R., Zhang H., Morris M., et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248 (2008) 807-816
30. Panesar M., Banerjee S., Barone G.W., et al. Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation. Clin Transplant 22 (2008) 803-808